This was a retrospective observational cohort study using patient data from the Get With The Guideline-Heart Failure (GWTG-HF) registry linked to Medicare Fee-for-Service (FFS) claims. The main goal of the study was to compare home-time in Medicare FFS patients with heart failure with mildly reduced or preserved ejection fraction discharged with sacubitril/valsartan versus those discharged without sacubitril/valsartan.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Time Spent 30 Days Post-discharge by Discharge Sacubitril/Valsartan (SAC/VAL) Prescription Status
Timeframe: Post-discharge at Day 30
Time Spent 90 Days Post-discharge by Discharge SAC/VAL Prescription Status
Timeframe: Post-discharge at Day 90
Time Spent 180 Days Post-discharge by Discharge SAC/VAL Prescription Status
Timeframe: Post-discharge at Day 180
Time Spent 365 Days Post-discharge by Discharge SAC/VAL Prescription Status
Timeframe: Post-discharge at Day 365